Edition:
United Kingdom

Natus Medical Inc (BABY.OQ)

BABY.OQ on NASDAQ Stock Exchange Global Select Market

33.65USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$33.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,784
52-wk High
$43.55
52-wk Low
$28.05

Chart for

About

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $1,340.90
Shares Outstanding(Mil.): 33.15
Dividend: --
Yield (%): --

Financials

  BABY.OQ Industry Sector
P/E (TTM): 67.43 148.68 32.76
EPS (TTM): 0.60 -- --
ROI: 3.83 9.38 14.61
ROE: 4.58 14.71 16.33

CORRECTED-Hedge fund Voce's nominees elected to Natus board

June 22 Natus Medical Inc said on Friday its stockholders had elected hedge fund Voce Capital Management's nominees to the company's board, ending a months long proxy fight.

24 Jun 2018

UPDATE 1-In Natus proxy fight, Glass Lewis supports Voce nominees

BOSTON, June 13 Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management's nominees.

14 Jun 2018

In Natus proxy fight, Glass Lewis supports Voce nominees

BOSTON, June 13 Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management's nominees.

13 Jun 2018

BRIEF-Voce Catalyst Urges Natus Medical Shareholders To Vote For Election Of Its Nominees, Removal Of Co's Chairman

* VOCE CATALYST PARTNERS LP URGES NATUS MEDICAL INC SHAREHOLDERS TO VOTE FOR ELECTION OF ITS NOMINEES AND FOR REMOVAL OF CO'S CHAIRMAN

07 May 2018

BRIEF-Natus Medical Reports Q1 Non-GAAP Earnings Per Share Of $0.24

* Q1 EARNINGS PER SHARE VIEW $0.24 -- THOMSON REUTERS I/B/E/S

25 Apr 2018

BRIEF-Natus Medical Inc Confirms Receipt Of Notice From Voce Capital

* NATUS CONFIRMS RECEIPT OF NOTICE OF VOCE CAPITAL’S INTENT TO NOMINATE DIRECTOR CANDIDATES TO REPLACE 50% OF THE NATUS BOARD

23 Apr 2018

Earnings vs. Estimates